Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yarrow BioscienceYARW -2.78%13 FCF Yield % is -8.46 as of Sep. 14, 2026. GuruFocus rates YARW with a GF Score™ of 13/100. Among 1,405 Biotechnology companies, Yarrow Bioscience ranks better than 53.67% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Yarrow Bioscience FCF Yield % Related Terms
Yarrow Bioscience FCF Yield % Historical Data
* Premium members only.
The historical data trend for Yarrow Bioscience's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yarrow Bioscience FCF Yield % Chart
Yarrow Bioscience Annual Data
Trend
Dec25
FCF Yield %
0.00
Yarrow Bioscience Quarterly Data
Jun25
Dec25
Mar26
Jun26
FCF Yield %
0.00
0.00
0.00
0.00
YARW vs CGTX, RANI, VRCA: FCF Yield % Comparison
For the Biotechnology subindustry, Yarrow Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yarrow Bioscience FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Yarrow Bioscience's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Yarrow Bioscience's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yarrow Bioscience (YARW) has a FCF Yield % of -8.46 as of Sep. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Yarrow Bioscience and its competitors. According to the industry distribution chart, Yarrow Bioscience ranks #651 out of 1405 companies in the Biotechnology industry, placing it in the top 46.3%.
Is Yarrow Bioscience's FCF Yield % too high?
Yarrow Bioscience's current FCF Yield % is -8.46. Based on the distribution chart, Yarrow Bioscience ranks #651 out of 1405 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Yarrow Bioscience has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's FCF Yield % compare to CGTX and RANI?
According to the Biotechnology industry distribution chart, Yarrow Bioscience ranks #651 out of 1405 companies for FCF Yield %. This puts Yarrow Bioscience in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Yarrow Bioscience and its competitors. Yarrow Bioscience's current FCF Yield % is -8.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current FCF Yield % of -8.46. The current FCF Yield % is -8.46. Yarrow Bioscience's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current FCF Yield % is -8.46 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
13GF Score
Get the complete analysis for YARW
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YARW has been successfully added to your 
